Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Nemychenkov NS"'
Autor:
Wang Y; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Department of Hematology, The Second Xiangya Hospital, Central South University, Changsha, China., Ullah MA; QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia., Waltner OG; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA., Bhise SS; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA., Ensbey KS; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA., Schmidt CR; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA., Legg SR; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA., Sekiguchi T; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA., Nelson EL; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA., Kuns RD; QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia., Nemychenkov NS; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA., Atilla E; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA., Yeh AC; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA., Takahashi S; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA., Boiko JR; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA., Varelias A; QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.; Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia., Blazar BR; Department of Pediatrics, University of Minnesota, Minneapolis, Minnesota, USA., Koyama M; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA., Minnie SA; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA., Clouston AD; Envoi Pathology, Brisbane, Queensland, Australia., Furlan SN; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Department of Pediatrics and., Zhang P; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA., Hill GR; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Division of Medical Oncology, University of Washington, Seattle, Washington, USA.
Publikováno v:
The Journal of clinical investigation [J Clin Invest] 2024 Jun 03; Vol. 134 (11). Date of Electronic Publication: 2024 Jun 03.
Autor:
Minnie SA; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Waltner OG; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Zhang P; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Takahashi S; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Nemychenkov NS; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Ensbey KS; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Schmidt CR; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Legg SRW; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Comstock M; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Boiko JR; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Department of Pediatrics, University of Washington, Seattle, WA, USA., Nelson E; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Bhise SS; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Wilkens AB; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Koyama M; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Dhodapkar MV; Department of Hematology/Medical Oncology, Emory University, Atlanta, GA, USA.; Winship Cancer Institute, Emory University, Atlanta, GA, USA., Chesi M; Department of Medicine, Division of Hematology/Oncology, Mayo Clinic, Scottsdale, AZ, USA., Riddell SR; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Division of Medical Oncology, University of Washington, Seattle, WA, USA., Green DJ; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Division of Medical Oncology, University of Washington, Seattle, WA, USA., Spencer A; Australian Center for Blood Diseases, Monash University/Alfred Hospital, Melbourne, VIC, Australia.; Department of Clinical Haematology, Monash University, Melbourne, VIC, Australia.; Malignant Haematology and Stem Cell Transplantation, Alfred Hospital, Melbourne, VIC, Australia., Furlan SN; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Department of Pediatrics, University of Washington, Seattle, WA, USA., Hill GR; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Division of Medical Oncology, University of Washington, Seattle, WA, USA.
Publikováno v:
Science immunology [Sci Immunol] 2024 Apr 19; Vol. 9 (94), pp. eadg1094. Date of Electronic Publication: 2024 Apr 19.
Autor:
Minnie SA; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA., Waltner OG; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA., Ensbey KS; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA., Olver SD; QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia., Collinge AD; QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia., Sester DP; Translational Research Institute, Woolloongabba, Queensland, Australia.; Hugh Green Cytometry Centre, Malaghan Institute of Medical Research, Wellington, New Zealand., Schmidt CR; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA., Legg SR; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA., Takahashi S; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA., Nemychenkov NS; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA., Sekiguchi T; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA., Driessens G; iTeos Therapeutics, Gosselies, Belgium., Zhang P; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA., Koyama M; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA., Spencer A; Australian Center for Blood Diseases, Monash University and.; Malignant Haematology and Stem Cell Transplantation, The Alfred Hospital, Melbourne, Victoria, Australia.; Department of Clinical Haematology, Monash University, Melbourne, Victoria, Australia., Holmberg LA; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Division of Medical Oncology and., Furlan SN; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Department of Pediatrics, University of Washington, Seattle, Washington, USA., Varelias A; QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.; Faculty of Medicine, The University of Queensland, St. Lucia, Queensland, Australia., Hill GR; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Division of Medical Oncology and.
Publikováno v:
The Journal of clinical investigation [J Clin Invest] 2023 Feb 15; Vol. 133 (4). Date of Electronic Publication: 2023 Feb 15.
Autor:
Minnie SA; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA., Waltner OG; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA., Ensbey KS; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA., Nemychenkov NS; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA., Schmidt CR; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA., Bhise SS; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA., Legg SRW; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA., Campoy G; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA., Samson LD; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA., Kuns RD; QIMR Berghofer Medical Research Institute, Brisbane, QLD 4006, Australia., Zhou T; Department of Immunobiology, Yale School of Medicine, New Haven, CT 06519, USA., Huck JD; Department of Immunobiology, Yale School of Medicine, New Haven, CT 06519, USA., Vuckovic S; QIMR Berghofer Medical Research Institute, Brisbane, QLD 4006, Australia., Zamora D; Department of Medicine, University of Washington, Seattle, WA 98109, USA.; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA., Yeh A; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.; Department of Medicine, University of Washington, Seattle, WA 98109, USA., Spencer A; Australian Center for Blood Diseases, Monash University/the Alfred Hospital, Melbourne, VIC 3004, Australia.; Malignant Haematology and Stem Cell Transplantation, the Alfred Hospital, Melbourne, VIC 3004, Australia.; Department of Clinical Haematology, Monash University, Melbourne, VIC 3800, Australia., Koyama M; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA., Markey KA; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.; Department of Medicine, University of Washington, Seattle, WA 98109, USA., Lane SW; QIMR Berghofer Medical Research Institute, Brisbane, QLD 4006, Australia., Boeckh M; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.; Department of Medicine, University of Washington, Seattle, WA 98109, USA.; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA., Ring AM; Department of Immunobiology, Yale School of Medicine, New Haven, CT 06519, USA., Furlan SN; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.; Department of Pediatrics, University of Washington, Seattle, WA 98105, USA., Hill GR; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.; Department of Medicine, University of Washington, Seattle, WA 98109, USA.
Publikováno v:
Science immunology [Sci Immunol] 2022 Oct 21; Vol. 7 (76), pp. eabo3420. Date of Electronic Publication: 2022 Oct 14.